All stock lists
Unlock the score
Enovis CORP (New York Stock Exchange:ENOV)
US · Delayed Price · Currency is USD
Also listed: 0I1B.LHealthcare · Medical - Devices
21.02-0.06 (-0.28%)
Insider Score
/ 100
ENOV Insider Score
Enovis CORP has a live Insider Score.
Scored on 4 qualifying trades from 2 insiders in the last 90 days.
ENOV Income Statement
| Fiscal Period | Q3 2026 | Q2 2026 | Q4 2025 | Q4 2025 | Q3 2025 | Q2 2025 |
|---|---|---|---|---|---|---|
| Period Ending | Jul 3, 2026 | Apr 3, 2026 | Dec 31, 2025 | Oct 3, 2025 | Jul 4, 2025 | Apr 4, 2025 |
| Revenue | 582.78 M | 589.15 M | 575.76 M | 548.91 M | 564.54 M | 558.83 M |
| Revenue Growth (YoY) | 3.23 % | 5.43 % | 2.64 % | 8.65 % | 7.50 % | 8.25 % |
| Cost of Revenue | 223.53 M | 265.57 M | 226.34 M | 262.19 M | 229.85 M | 226.60 M |
| Gross Profit | 359.25 M | 323.58 M | 349.42 M | 286.72 M | 334.70 M | 332.23 M |
| SG&A Expense | 263.73 M | 271.78 M | 270.44 M | 247.95 M | 267.07 M | 269.02 M |
| R&D Expense | 31.69 M | 31.53 M | 31.36 M | 29.74 M | 30.70 M | 28.53 M |
| Operating Expenses | 341.84 M | 303.31 M | 301.17 M | 277.69 M | 350.78 M | 375.14 M |
| Operating Income | 17.41 M | 20.27 M | 48.25 M | 9.04 M | -16.08 M | -42.91 M |
| Pretax Income | 7.46 M | 634.00 K | -509.55 M | -566.87 M | -25.65 M | -57.35 M |
| Tax Provision | 8.50 M | 9.04 M | 9.26 M | 4.00 M | 10.80 M | -1.77 M |
| Net Income | -1.19 M | -8.76 M | -520.59 M | -571.15 M | -36.74 M | -55.97 M |
| EPS (Basic) | -0.02 | -0.15 | -9.17 | -10.06 | -0.64 | -0.99 |
| EPS (Diluted) | -0.02 | -0.15 | -9.17 | -10.06 | -0.64 | -0.99 |
| Shares Outstanding | 57.60 M | 56.79 M | 56.79 M | 56.79 M | 56.79 M | 56.79 M |
Quarterly figures; YoY compares the same fiscal quarter a year earlier. Source: public market data.
Disclaimer — Informational only — not investment advice. Insider transaction data is sourced from SEC Form 4 filings; market data from public feeds and may be delayed. The Insider Score is a proprietary score for research purposes and does not predict future performance. Always do your own research.
